These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
710 related articles for article (PubMed ID: 32515468)
1. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway. Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468 [TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells. Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416 [TBL] [Abstract][Full Text] [Related]
3. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways. Xiong Y; Wang J; Wang S; Li H; Zhou X J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401 [TBL] [Abstract][Full Text] [Related]
4. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194 [TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
6. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells. Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y Front Immunol; 2021; 12():635076. PubMed ID: 34025642 [TBL] [Abstract][Full Text] [Related]
7. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways. Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135 [TBL] [Abstract][Full Text] [Related]
8. Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways. Liu A; Zhang B; Zhao W; Tu Y; Wang Q; Li J Bioengineered; 2021 Dec; 12(1):183-195. PubMed ID: 33323018 [TBL] [Abstract][Full Text] [Related]
9. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway. Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970 [TBL] [Abstract][Full Text] [Related]
10. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway. Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation. Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957 [TBL] [Abstract][Full Text] [Related]
12. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840 [TBL] [Abstract][Full Text] [Related]
13. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways. Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms. Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843 [TBL] [Abstract][Full Text] [Related]
15. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes. Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203 [TBL] [Abstract][Full Text] [Related]
16. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674 [TBL] [Abstract][Full Text] [Related]
17. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. Guo H; Li M; Liu H Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231 [TBL] [Abstract][Full Text] [Related]
18. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related]
19. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice. Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197 [TBL] [Abstract][Full Text] [Related]
20. Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB/c mice by inhibiting the MAPK signaling pathway. Long Q; Ma T; Wang Y; Chen S; Tang S; Wang T; Zhou Y; Xu K; Wan P; Cao Y Int Immunopharmacol; 2024 Jun; 134():112261. PubMed ID: 38761783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]